RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept
Newsroom

Expert Available to Comment on Potential COVID-19 Booster Shots, Global Vaccination Efforts

RESEARCH TRIANGLE PARK, N.C. — Richard Reithinger, Ph.D., Vice President of Global Health at RTI International, a nonprofit research institute, is available for media interviews on global COVID-19 vaccination planning, vaccine disparities and whether a third dose or booster shot should be prioritized in the United States. Vaccine makers have announced plans to seek authorization for supplementary doses, yet many countries around the world still do not have vaccines available for all and their populations are at a greater risk of infection and disease.

Dr. Reithinger has participated in several media interviews throughout the COVID-19 pandemic to provide insight on global vaccine distribution planning and vaccine diplomacy. He can speak to the benefits and risks of prioritizing a third dose of the COVID-19 vaccine in the US versus ramping up vaccination efforts in other countries across the globe. Dr. Reithinger can also comment on the importance of working together with low-and-middle-income countries to roll out COVID-19 vaccines, while simultaneously prioritizing programs to eliminate other diseases.

Prior to his position at RTI, Dr. Reithinger worked for the US Agency for International Development (USAID) as the President’s Malaria Initiative (PMI) Team Leader and Malaria Advisor in Ethiopia. He has been published widely on the topics of infectious disease prevention, control and surveillance.

To set up an interview with Dr. Reithinger contact news@rti.org.